The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: -0.10 (-5.88%)
Spread: 0.20 (13.333%)
Open: 1.65
High: 1.65
Low: 1.60
Prev. Close: 1.70
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

26 Nov 2020 07:00

RNS Number : 5438G
IQ-AI Limited
26 November 2020
 

26 November 2020

IQ-AI Ltd

("IQ-AI" or the "Company")

IMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE

 

IQ-AI today announces that its subsidiary, Imaging Biometrics®, LLC (IB), has made available release 20.11 of its IB Clinic™ software platform. The new release incorporates multiple new enhancement requests received from clients, as well as workflow efficiencies engineered by IB's developers. Ultimately, this release underscores IB's commitment to quality and helping clinicians improve care for their patients.

 

IB Clinic consists of perfusion weighted imaging and permeability computation modules IB Neuro and IB DCE, diffusion weighted imaging analysis module IB Diffusion, image co-registration and manipulation module IB Delta Suite, and IB Rad Tech, which streamlines and automates customizable workflows. While the products contained in IB Clinic continue to be available as plugins to the Mac-based medical imaging viewers, aycan workstation and OsiriX MD, they are also now available as platform-independent automated applications for both in-house and cloud-based processing. Both options generate consistent quantitative output regardless of where or when a patient is scanned, a feature unique to IB Clinic.

 

"This latest release further builds upon our proven track record of delivering scientifically proven advancements to clinicians," said Michael Schmainda, CEO of IB.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

 

-ENDS-

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

ABOUT Imaging Biometrics, LLC

Imaging Biometrics®, a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat disease with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent and automated software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBABLTMTMTBIM
Date   Source Headline
4th Jun 20085:35 pmRNSHolding(s) in Company
2nd Jun 20089:59 amRNSCEO Appointment
29th May 20083:30 pmRNSTrading Statement
8th May 20085:01 pmRNSAnnual Information Update
8th May 20084:27 pmRNSBlocklisting Interim Review
8th May 20084:26 pmRNSAnnual Report and Accounts
23rd Apr 200810:19 amRNSAGM Statement
14th Mar 20087:01 amRNSFinal Results
29th Feb 20087:01 amRNSNotice of Final Results
17th Jan 20081:39 pmRNSTrading Statement
13th Nov 20075:59 pmRNSHolding(s) in Company
23rd Oct 20077:02 amRNSTrading Update
27th Sep 200711:18 amRNSTotal Voting Rights
26th Sep 200711:00 amRNSBlocklisting Interim Review
6th Sep 20073:27 pmRNSDirectorate Change
27th Jul 20077:01 amRNSInterim Results
9th Jul 20077:00 amRNSNotice of Interim Results
6th Jul 200710:50 amRNSHolding(s) in Company
1st Jun 20078:00 amRNSHolding(s) in Company
8th May 20072:29 pmRNSDirector/PDMR Shareholding
25th Apr 200710:10 amRNSHolding(s) in Company
17th Apr 200710:44 amRNSAGM Statement & Board Changes
27th Mar 20072:40 pmRNSBlocklisting Interim Review
20th Mar 20079:01 amRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results
22nd Jan 20077:02 amRNSTrading Statement
19th Jan 20072:45 pmRNSHolding(s) in Company
15th Jan 20071:41 pmRNSHolding(s) in Company
13th Dec 200612:19 pmRNSTotal Voting Rights
29th Nov 20069:01 amRNSShareholder & Board Change
18th Oct 20062:16 pmRNSHolding(s) in Company
16th Oct 200611:49 amRNSHolding(s) in Company
26th Sep 200610:31 amRNSBlocklisting Interim Review
21st Sep 200610:12 amRNSHolding(s) in Company
18th Sep 20067:01 amRNSAcquisition
10th Aug 200610:19 amRNSHolding(s) in Company
8th Aug 20067:01 amRNSTransaction in Own Shares
28th Jul 20067:01 amRNSInterim Results
18th Jul 20067:00 amRNSNotice of Interim Results
27th Jun 20064:52 pmRNSChange of Auditors
3rd May 20065:09 pmRNSDirectorate Change
28th Apr 20067:01 amRNSHolding(s) in Company
13th Apr 200610:15 amRNSAGM Statement
6th Apr 200610:26 amRNSDirector/PDMR Shareholding
24th Mar 20064:17 pmRNSAdditional Listing - Replace
23rd Mar 20063:28 pmRNSAdditional Listing
16th Mar 20063:18 pmRNSDirector/PDMR Shareholding
14th Mar 20063:43 pmRNSAnnual Information Update
14th Mar 200612:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.